Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Gene |
RCV000522047 | SCV000618144 | likely pathogenic | not provided | 2017-04-04 | criteria provided, single submitter | clinical testing | A variant that is likely pathogenic has been identified in the TPM3 gene. The A152V variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. It was not observed in approximately 6,500 individuals of European and African American ancestry in an external variant database, indicating it is not a common benign variant in these populations. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Missense variants in nearby residues (L149I, E151A, A156T) have been reported in the Human Gene Mutation Database in association with TPM3-related disorders (Stenson et al., 2014), supporting the functional importance of this region of the protein. However, the A152V variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. Targeted parental testing indicates this variant is apparently de novo in this individual. Therefore, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded.TPM3-related disorders can be inherited in an autosomal dominant or autosomal recessive manner, however, this variant appears to be associated with an autosomal dominant presentation in this individual. |
| Labcorp Genetics |
RCV001857960 | SCV002238657 | pathogenic | Congenital myopathy 4B, autosomal recessive; Congenital myopathy with fiber type disproportion | 2022-10-17 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of congenital myopathy (Invitae). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 449764). This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 152 of the TPM3 protein (p.Ala152Val). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TPM3 protein function. For these reasons, this variant has been classified as Pathogenic. |